can j clin pharmacol vol 14 1 winter 2007 e70 e80 march 2 canadian society for clinical pharmacology all rights reserved use of celecoxib immediately post marketing in canada acute or chronic pain anita l kozyrskyj1 colette raymond1 amber racher1 1faculty pharmacy university manitoba 2dept community health sciences centre policy dept pediatrics and child faculty medicine corresponding author kozyrsk cc umanitoba ca _____________________________________________________________________________________ abstract objectives the diffusion innovations theory suggests that early users influence others this study was undertaken to apply prescribing determine if prescriber patient characteristics differed amongst versus musculoskeletal conditions methods using s population based prescription care databases time from market availability first determined each curves were compared separately likelihood being an late user according physician factors specialty place
